Notification report

Full notification file

General information

Notification Number

Member State to which the notification was sent

Date of acknowledgement from the Member State Competent Authority

Title of the Project
A Global Study of a Single, One-Time Dose of AVXS-101 Delivered to Infants with Genetically Diagnosed and Pre-symptomatic Spinal Muscular Atrophy with Multiple Copies of SMN2

Proposed period of release:
01/04/2018 to 30/06/2023

Name of the Institute(s) or Company(ies)
AveXis, Inc., 2275 Half Day Road, Suite 200 Bannockburn, IL 60015, United States;

3. Is the same GMO release planned elsewhere in the Community?
Belgium; Germany; Spain; Italy; Netherlands;

Has the same GMO been notified elsewhere by the same notifier?

If yes, notification number(s):

GMO characterization

GMO is a:
DNA Virus

Identity of the GMO:
Family: Parvoviridae
Genus: Dependovirus
Species: Adeno-associated Virus (AAV9-derived replication-deficient viral vector containing
human SMN cDNA)

Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar
-DependovirusAdeno-associated Virus--Serotype 2 and 9

European Commission administrative information

Consent given by the Member State Competent Authority:
10/07/2018 00:00:00